GMP IPO
📋 Filings Intelligence
About Contact
LIVE - Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement - financial results, order wins, dividends, mergers and more. Updated live.

-
Filed today
-
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings -

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Krishna Institute of Medical Sciences Ltd

KIMS Fund Utilisation Report: NIL Deviation in Rs. 1500 Cr QIP Proceeds

FUNDRAISE ● No Immediate Change LOW RISK
📅 Filed on BSE: 04 Nov 2026, 09:01 PM IST  ·  BSE ID: cd9c2e2c-eef1-4fd8-af0c-bf16f57e1edd
View Original BSE Filing (PDF)
💡
In Simple Terms
The company confirmed all money raised from investors was spent exactly as promised for specific company needs.
🤖 AI Summary
  • Krishna Institute of Medical Sciences Ltd reported NIL deviation in QIP fund utilisation for Q2 FY27.
  • Rs. 1500 Crore raised via QIP on June 19, 2026, used as per placement document.
  • Funds were allocated for debt repayment and investments into subsidiaries.
  • The Audit Committee reviewed and noted no deviation in fund utilisation.
🔢 Key Numbers - exact figures from BSE filing, not rounded
Amount Raised
Rs. 1500 Cr
Quarter ended
30th September, 2026
Date of Raising Funds
19th June, 2026
Funds Utilised
1,332.00 Rs. Crore
Amount of Deviation/Variation for the quarter
Nil
🏢 How This Affects the Company
📈
Business Impact
Confirms adherence to capital allocation plans, maintaining investor confidence in the company's financial discipline.
💰
Financial Impact
The Rs. 1500 Crore QIP funds were utilised for specified purposes like debt repayment and subsidiary investment, impacting the balance sheet.
⚠️
Risk Impact
Reduces perceived risk associated with the QIP, as fund utilisation aligns with stated objectives.
👥 What This Means For Shareholders
✅
Action Required
No action is required by shareholders regarding this filing.
👤
Who Is Affected
All shareholders are informed of the proper utilisation of the Rs. 1500 Crore QIP proceeds.
🔍
Management Signal
Management signals commitment to transparent and planned deployment of raised capital according to the placement document.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List - track these upcoming events
Next quarterly results update for Q3 FY27.
Monitoring further utilisation of remaining QIP funds.
Confirmation of debt repayment and subsidiary investment progress.
LOW RISK Filing confirms no deviation, indicating adherence to capital allocation and regulatory compliance.
💡 Investor Takeaway
Krishna Institute of Medical Sciences Ltd confirmed zero deviation in the utilisation of Rs. 1500 Crore QIP funds raised on June 19, 2026, with all amounts allocated to debt repayment and subsidiary investments as planned.
⚖️ Strengths & Concerns

✅ Positives

  • Zero deviation confirmed in the utilisation of Rs. 1500 Crore QIP funds as of September 30, 2026.
  • Audit Committee review confirms adherence to the placement document's stated objects for fund deployment.
📅 Company Track Record
Krishna Institute of Medical Sciences Ltd raised Rs. 15,000 million (Rs. 1500 Cr) via QIP on June 19, 2026, allotting 1.98 Cr shares at Rs. 755 per share. Previous monitoring reports confirmed funds used as planned.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
What is the key information in Krishna Institute of Medical Sciences Ltd's QIP deviation report?
The company confirmed NIL deviation or variation in the utilisation of Rs. 1500 Cr raised through Qualified Institutional Placement for the quarter ended September 30, 2026.
When were the Rs. 1500 Crore QIP funds raised by KIMS?
The funds were raised on June 19, 2026.
What were the stated objects for the QIP funds raised by KIMS?
The funds were allocated for repayment/prepayment of certain outstanding borrowings and investment into subsidiaries for similar purposes, along with issue expenses.
Did KIMS deviate from its QIP fund utilisation plan in Q2 FY27?
No, the company's Audit Committee confirmed that there was NIL deviation or variation in the utilisation of funds raised from the objects stated in the offer document.

Questions based on this BSE filing only. For information purposes.

You've read one filing

There are 32,000 more, and one of them is about a company you own

Follow a company and we'll email you the moment it files again - explained, not just forwarded. Free.

  • Follow companies and get filings by email
  • Save any filing to read later
  • Two full AI analyses every month, free

No card needed. Sign in with Google in two taps.

⚠️ For Information Only - Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector - takes 5 seconds.